Mindray Announced Shareholder Resolutions post Annual General Meeting 2012

  Mindray Announced Shareholder Resolutions post Annual General Meeting 2012

PR Newswire

SHENZHEN, China, Dec. 31, 2012

SHENZHEN, China, Dec. 31, 2012 /PRNewswire-FirstCall/ -- Mindray Medical
International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer
and marketer of medical devices worldwide, today announced shareholder
resolutions adopted at its annual general meeting of shareholders held in Hong
Kong on December 28,2012.

At the meeting, Mindray shareholders approved the re-election of incumbent
directors Xu Hang, Ronald Ede and Chen Qingtai, each to serve a three-year
term.

In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the Company's independent registered public
accounting firm for the fiscal year ending December 31, 2012.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices
worldwide. We maintain our global headquarters inShenzhen, China, U.S.
headquarters inMahwah, New Jerseyand multiple sales offices in major
international markets. From our main manufacturing and engineering base
inChina, we supply through our worldwide distribution network a broad range
of products across three primary business segments, namely patient monitoring
and life support, in-vitro diagnostic, and medical imaging systems. For more
information, please visithttp://ir.mindray.com.

For investor and media inquiries please contact:

In the U.S:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com

In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com

SOURCE Mindray Medical International Limited

Website: http://ir.mindray.com
 
Press spacebar to pause and continue. Press esc to stop.